We are pleased to announce that our abstract has been selected for an oral presentation at APASL 2024. The Asia-Pacific Association for the Study of Liver (APASL) Congress is an important event in the field of hepatology, bringing together experts from around the globe to discuss the latest advancements, research findings, and clinical insights.
Our presentation promises to contribute valuable insights to the conference program. We are honoured to have this platform to share our research and engage with fellow professionals in the field.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
